Wyniki wyszukiwania:
wyszukanych pozycji: 6
 |
Price Comparisons for Pharmaceuticals: A Review of U.S. and Cross-National Studies
ISBN: 9780844771335 / Angielski / Miękka / 1999 / 55 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. Drug coverage for seniors is better addressed by private-sector plans than by forcing manufacturers to offer Federal Supply Schedule discounts to the retail sector.
Drug coverage for seniors is better addressed by private-sector plans than by forcing manufacturers to offer Federal Supply Schedule discounts to the ...
|
cena:
38,03 |
 |
Medical Malpractice
ISBN: 9780674331136 / Angielski / Twarda / 1985 / 270 str. Termin realizacji zamówienia: ok. 30 dni roboczych. How often are patients seriously injured through faulty medical care? And what proportion of these people receive compensation for their injuries and suffering? This is the first book that tries to answer these questions in a careful, scholarly way. Among its important findings is that at most one in ten patients injured through medical negligence receives compensation through the malpractice system.
The focus of public attention has been on the rising cost to physicians of malpractice insurance. Although Patricia Danzon analyzes this question thoroughly, her view is much... How often are patients seriously injured through faulty medical care? And what proportion of these people receive compensation for their injuries ... |
cena:
283,29 |
 |
Ohb Econ of Biopharma Ind Ohbk C
ISBN: 9780199742998 / Angielski / Twarda / 2012 / 624 str. Termin realizacji zamówienia: ok. 30 dni roboczych. The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster...
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost cha...
|
cena:
748,69 |
 |
Global Budgets Versus Competitive Cost-Control Strategies
ISBN: 9780844770239 / Angielski / Miękka / 1994 / 23 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. This text pinpoints the loss in economic efficiency from global budgeting and its likely distributive effects.
This text pinpoints the loss in economic efficiency from global budgeting and its likely distributive effects.
|
cena:
38,03 |
 |
Pharmaceutical Price Regulation: National Policies Versus Global Interests
ISBN: 9780844739830 / Angielski / Miękka / 1998 / 107 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. |
cena:
57,14 |
 |
Rate Regulation of Worker's Compensation Insurance: How Price Controls Increaee Cost
ISBN: 9780844739335 / Angielski / Miękka / 1998 / 170 str. Termin realizacji zamówienia: ok. 16-18 dni roboczych. This text defines the problem, describes the regulatory response and analyzes the effects of rate regulation. It demonstrates how regulation intended to control costs can exacerbate cost growth by subsidizing high-risk activities and firms at the expense of low-risk activities and firms.
This text defines the problem, describes the regulatory response and analyzes the effects of rate regulation. It demonstrates how regulation intended ...
|
cena:
57,14 |
Czytaj nas na:
KrainaKsiazek.PL - Księgarnia Internetowa
